Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$204.13 - $302.4 $2,041 - $3,024
10 Added 0.17%
5,738 $1.23 Million
Q1 2022

May 12, 2022

SELL
$255.51 - $362.11 $17,630 - $24,985
-69 Reduced 1.19%
5,728 $1.63 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $29,065 - $35,747
-78 Reduced 1.33%
5,797 $2.39 Million
Q1 2021

May 12, 2021

SELL
$249.67 - $299.48 $38,199 - $45,820
-153 Reduced 2.54%
5,875 $1.7 Million
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $105,006 - $119,489
473 Added 8.51%
6,028 $1.51 Million
Q3 2020

Nov 13, 2020

BUY
$175.56 - $226.45 $57,759 - $74,502
329 Added 6.3%
5,555 $1.26 Million
Q2 2020

Aug 13, 2020

SELL
$118.84 - $189.72 $4,159 - $6,640
-35 Reduced 0.67%
5,226 $911,000
Q1 2020

May 12, 2020

SELL
$98.9 - $178.34 $989 - $1,783
-10 Reduced 0.19%
5,261 $664,000
Q4 2019

Feb 06, 2020

SELL
$126.05 - $152.76 $2,268 - $2,749
-18 Reduced 0.34%
5,271 $805,000
Q3 2019

Nov 05, 2019

SELL
$125.07 - $143.67 $23,388 - $26,866
-187 Reduced 3.41%
5,289 $700,000
Q2 2019

Aug 06, 2019

SELL
$123.4 - $148.55 $10,489 - $12,626
-85 Reduced 1.53%
5,476 $777,000
Q1 2019

May 14, 2019

SELL
$104.82 - $146.73 $57,860 - $80,994
-552 Reduced 9.03%
5,561 $808,000
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $46,029 - $60,106
-438 Reduced 6.69%
6,113 $692,000
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $65,920 - $79,109
588 Added 9.86%
6,551 $881,000
Q2 2018

Aug 14, 2018

BUY
$102.37 - $117.25 $610,432 - $699,161
5,963 New
5,963 $669,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track 1492 Capital Management LLC Portfolio

Follow 1492 Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.